Chronic nightly dosing of lasmiditan for migraine prevention

Chronic nightly dosing of lasmiditan for migraine prevention

The present invention relates to chronic nightly use of lasmiditan for the prevention of migraine, particularly therapy resistant migraine which is defined herein as migraine refractory to two or more prior monotherapy and/or dual therapy treatment or prevention regimens.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Johnson, Kirk Willis, Davar, Gudarz, Conley, Robert Russell
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Johnson, Kirk Willis
Davar, Gudarz
Conley, Robert Russell
description The present invention relates to chronic nightly use of lasmiditan for the prevention of migraine, particularly therapy resistant migraine which is defined herein as migraine refractory to two or more prior monotherapy and/or dual therapy treatment or prevention regimens.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US12138254B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US12138254B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US12138254B23</originalsourceid><addsrcrecordid>eNrjZLBxzijKz8tMVsjLTM8oyalUSMkvzsxLV8hPU8hJLM7NTMksScxTSMsvUsjNTC9KzMxLVSgoSi1LzSvJzM_jYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxocGGRobGFkamJk5GxsSoAQAOfDBM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Chronic nightly dosing of lasmiditan for migraine prevention</title><source>esp@cenet</source><creator>Johnson, Kirk Willis ; Davar, Gudarz ; Conley, Robert Russell</creator><creatorcontrib>Johnson, Kirk Willis ; Davar, Gudarz ; Conley, Robert Russell</creatorcontrib><description>The present invention relates to chronic nightly use of lasmiditan for the prevention of migraine, particularly therapy resistant migraine which is defined herein as migraine refractory to two or more prior monotherapy and/or dual therapy treatment or prevention regimens.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20241112&amp;DB=EPODOC&amp;CC=US&amp;NR=12138254B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20241112&amp;DB=EPODOC&amp;CC=US&amp;NR=12138254B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Johnson, Kirk Willis</creatorcontrib><creatorcontrib>Davar, Gudarz</creatorcontrib><creatorcontrib>Conley, Robert Russell</creatorcontrib><title>Chronic nightly dosing of lasmiditan for migraine prevention</title><description>The present invention relates to chronic nightly use of lasmiditan for the prevention of migraine, particularly therapy resistant migraine which is defined herein as migraine refractory to two or more prior monotherapy and/or dual therapy treatment or prevention regimens.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLBxzijKz8tMVsjLTM8oyalUSMkvzsxLV8hPU8hJLM7NTMksScxTSMsvUsjNTC9KzMxLVSgoSi1LzSvJzM_jYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxocGGRobGFkamJk5GxsSoAQAOfDBM</recordid><startdate>20241112</startdate><enddate>20241112</enddate><creator>Johnson, Kirk Willis</creator><creator>Davar, Gudarz</creator><creator>Conley, Robert Russell</creator><scope>EVB</scope></search><sort><creationdate>20241112</creationdate><title>Chronic nightly dosing of lasmiditan for migraine prevention</title><author>Johnson, Kirk Willis ; Davar, Gudarz ; Conley, Robert Russell</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US12138254B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Johnson, Kirk Willis</creatorcontrib><creatorcontrib>Davar, Gudarz</creatorcontrib><creatorcontrib>Conley, Robert Russell</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Johnson, Kirk Willis</au><au>Davar, Gudarz</au><au>Conley, Robert Russell</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Chronic nightly dosing of lasmiditan for migraine prevention</title><date>2024-11-12</date><risdate>2024</risdate><abstract>The present invention relates to chronic nightly use of lasmiditan for the prevention of migraine, particularly therapy resistant migraine which is defined herein as migraine refractory to two or more prior monotherapy and/or dual therapy treatment or prevention regimens.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US12138254B2
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Chronic nightly dosing of lasmiditan for migraine prevention
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T11%3A09%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Johnson,%20Kirk%20Willis&rft.date=2024-11-12&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS12138254B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true